Laboratory Capital Surpluse vs Net Tangible Assets Analysis

LH Stock

USD 198.40 0.05 0.03%

Laboratory financial indicator trend analysis is infinitely more than just investigating Laboratory recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Laboratory is a good investment. Please check the relationship between Laboratory Capital Surpluse and its Net Tangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Capital Surpluse vs Net Tangible Assets

Capital Surpluse vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Laboratory Capital Surpluse account and Net Tangible Assets. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Laboratory's Capital Surpluse and Net Tangible Assets is -0.41. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Laboratory of, assuming nothing else is changed. The correlation between historical values of Laboratory's Capital Surpluse and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of Laboratory of are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Capital Surpluse i.e., Laboratory's Capital Surpluse and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

-0.41

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Capital Surpluse

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Most indicators from Laboratory's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

As of now, Laboratory's Tax Provision is increasing as compared to previous years. The Laboratory's current Enterprise Value is estimated to increase to about 8.7 B, while Selling General Administrative is projected to decrease to under 1.1 B.

	2021	2022	2023	2024 (projected)
Gross Profit	5.6B	4.4B	3.1B	1.9B
Total Revenue	16.1B	14.9B	12.2B	12.8B

Gross Profit Total Revenue

Laboratory fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Inventory	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity
Common Stock Shares Outstanding		0.58	0.51	0.52	0.47	0.41	0.66	0.48	0.49	0.31	0.62	0.09	0.31	0.44	0.7	0.32	0.11	0.66	0.41	0.66	0.64	0.26	0.32	0.19	0.94	0.9
Total Assets	0.58		0.62	0.69	0.98	0.95	0.93	0.95	0.92	0.54	0.99	0.43	0.54	0.96	0.82	0.85	0.39	0.98	0.94	0.96	0.9	-0.01	0.85	0.76	0.57	0.32
Other Current Liab	0.51	0.62		0.81	0.65	0.55	0.45	0.68	0.47	0.53	0.6	0.53	0.53	0.68	0.53	0.4	-0.02	0.57	0.64	0.51	0.6	0.41	0.5	0.41	0.46	0.18
Total Current Liabilities	0.52	0.69	0.81		0.72	0.74	0.59	0.74	0.73	0.26	0.68	0.54	0.26	0.7	0.37	0.71	0.03	0.63	0.67	0.6	0.53	0.69	0.75	0.7	0.53	0.35
Total Stockholder Equity	0.47	0.98	0.65	0.72		0.96	0.84	0.98	0.92	0.56	0.95	0.53	0.56	0.99	0.72	0.87	0.28	0.92	0.97	0.88	0.83	0.0	0.91	0.84	0.48	0.19
Property Plant And Equipment Net	0.41	0.95	0.55	0.74	0.96		0.85	0.94	0.94	0.47	0.93	0.54	0.47	0.94	0.63	0.93	0.3	0.9	0.94	0.88	0.75	0.1	0.94	0.9	0.46	0.2
Net Debt	0.66	0.93	0.45	0.59	0.84	0.85		0.78	0.88	0.3	0.96	0.22	0.3	0.78	0.86	0.78	0.55	0.97	0.75	0.99	0.92	0.0	0.68	0.6	0.61	0.48
Retained Earnings	0.48	0.95	0.68	0.74	0.98	0.94	0.78		0.89	0.57	0.92	0.61	0.57	0.98	0.67	0.84	0.1	0.87	0.96	0.83	0.77	0.04	0.91	0.84	0.54	0.2
Accounts Payable	0.49	0.92	0.47	0.73	0.92	0.94	0.88	0.89		0.27	0.92	0.44	0.27	0.87	0.63	0.96	0.3	0.88	0.85	0.87	0.76	0.13	0.91	0.87	0.54	0.34
Cash	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27		0.47	0.36	1.0	0.63	0.52	0.24	0.04	0.5	0.7	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Non Current Assets Total	0.62	0.99	0.6	0.68	0.95	0.93	0.96	0.92	0.92	0.47		0.39	0.47	0.92	0.85	0.83	0.43	0.99	0.9	0.98	0.92	-0.01	0.81	0.72	0.59	0.37
Non Currrent Assets Other	0.09	0.43	0.53	0.54	0.53	0.54	0.22	0.61	0.44	0.36	0.39		0.36	0.55	0.23	0.44	-0.36	0.32	0.52	0.27	0.3	0.21	0.59	0.59	0.22	-0.17
Cash And Short Term Investments	0.31	0.54	0.53	0.26	0.56	0.47	0.3	0.57	0.27	1.0	0.47	0.36		0.63	0.52	0.25	0.04	0.5	0.71	0.45	0.45	-0.24	0.46	0.34	0.35	0.05
Net Receivables	0.44	0.96	0.68	0.7	0.99	0.94	0.78	0.98	0.87	0.63	0.92	0.55	0.63		0.7	0.83	0.22	0.89	0.98	0.84	0.8	-0.02	0.9	0.81	0.47	0.14
Non Current Liabilities Total	0.7	0.82	0.53	0.37	0.72	0.63	0.86	0.67	0.63	0.52	0.85	0.23	0.52	0.7		0.48	0.46	0.88	0.67	0.88	0.96	-0.23	0.44	0.32	0.64	0.43
Other Current Assets	0.32	0.85	0.4	0.71	0.87	0.93	0.78	0.84	0.96	0.24	0.83	0.44	0.25	0.83	0.48		0.29	0.79	0.83	0.78	0.63	0.18	0.93	0.94	0.4	0.22
Other Stockholder Equity	0.11	0.39	-0.02	0.03	0.28	0.3	0.55	0.1	0.3	0.04	0.43	-0.36	0.04	0.22	0.46	0.29		0.47	0.23	0.52	0.5	-0.22	0.12	0.1	-0.1	0.07
Total Liab	0.66	0.98	0.57	0.63	0.92	0.9	0.97	0.87	0.88	0.5	0.99	0.32	0.5	0.89	0.88	0.79	0.47		0.87	1.0	0.93	-0.03	0.76	0.66	0.63	0.43
Total Current Assets	0.41	0.94	0.64	0.67	0.97	0.94	0.75	0.96	0.85	0.7	0.9	0.52	0.71	0.98	0.67	0.83	0.23	0.87		0.83	0.75	-0.03	0.92	0.83	0.46	0.14
Short Long Term Debt Total	0.66	0.96	0.51	0.6	0.88	0.88	0.99	0.83	0.87	0.45	0.98	0.27	0.45	0.84	0.88	0.78	0.52	1.0	0.83		0.92	-0.04	0.73	0.63	0.63	0.46
Intangible Assets	0.64	0.9	0.6	0.53	0.83	0.75	0.92	0.77	0.76	0.45	0.92	0.3	0.45	0.8	0.96	0.63	0.5	0.93	0.75	0.92		-0.11	0.58	0.47	0.57	0.36
Short Term Debt	0.26	-0.01	0.41	0.69	0.0	0.1	0.0	0.04	0.13	-0.24	-0.01	0.21	-0.24	-0.02	-0.23	0.18	-0.22	-0.03	-0.03	-0.04	-0.11		0.18	0.19	0.26	0.32
Inventory	0.32	0.85	0.5	0.75	0.91	0.94	0.68	0.91	0.91	0.46	0.81	0.59	0.46	0.9	0.44	0.93	0.12	0.76	0.92	0.73	0.58	0.18		0.95	0.42	0.16
Property Plant And Equipment Gross	0.19	0.76	0.41	0.7	0.84	0.9	0.6	0.84	0.87	0.34	0.72	0.59	0.34	0.81	0.32	0.94	0.1	0.66	0.83	0.63	0.47	0.19	0.95		0.3	0.06
Common Stock	0.94	0.57	0.46	0.53	0.48	0.46	0.61	0.54	0.54	0.35	0.59	0.22	0.35	0.47	0.64	0.4	-0.1	0.63	0.46	0.63	0.57	0.26	0.42	0.3		0.87
Common Stock Total Equity	0.9	0.32	0.18	0.35	0.19	0.2	0.48	0.2	0.34	0.05	0.37	-0.17	0.05	0.14	0.43	0.22	0.07	0.43	0.14	0.46	0.36	0.32	0.16	0.06	0.87

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	98.6M	98M	97.5M	91.6M	87.6M	96.0M
Total Assets	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Other Current Liab	942.4M	1.4B	1.4B	1.1B	804M	502.9M
Total Current Liabilities	1.9B	2.6B	3.1B	2.8B	3.2B	3.4B
Total Stockholder Equity	7.6B	9.4B	10.3B	10.1B	7.9B	8.3B
Property Plant And Equipment Net	2.6B	2.7B	2.8B	3.0B	2.9B	3.1B
Net Debt	6.7B	5.4B	4.9B	5.9B	5.4B	5.7B
Retained Earnings	7.9B	9.4B	10.5B	10.6B	7.9B	8.3B
Accounts Payable	632.3M	638.9M	621.3M	934.8M	827.5M	868.9M
Cash	337.5M	1.3B	1.5B	430M	536.8M	290.8M
Non Current Assets Total	15.0B	14.9B	15.1B	15.5B	13.0B	13.6B
Non Currrent Assets Other	435.4M	410M	462.6M	432.7M	536.5M	270.8M
Cash And Short Term Investments	337.5M	1.3B	1.5B	430M	536.8M	299.7M
Net Receivables	2.0B	3.0B	3.0B	3.0B	2.1B	2.2B
Liabilities And Stockholders Equity	18.0B	20.1B	20.4B	20.2B	16.7B	17.6B
Non Current Liabilities Total	7.8B	7.6B	7.3B	7.0B	5.6B	3.1B
Other Current Assets	373.7M	364.8M	478.1M	707M	655.3M	688.1M
Other Stockholder Equity	26.8M	110.3M	(192M)	(493.2M)	38.4M	36.5M
Total Liab	10.5B	10.7B	10.1B	10.1B	8.8B	9.3B
Total Current Assets	3.0B	5.1B	5.3B	4.6B	3.8B	4.0B
Short Long Term Debt Total	7.1B	6.8B	6.3B	6.3B	6.0B	6.3B
Intangible Assets	4.0B	4.0B	3.7B	3.9B	3.3B	2.0B
Short Term Debt	621.1M	575.4M	199M	492.8M	1.2B	1.2B
Inventory	244.7M	423.2M	401.4M	470.6M	474.6M	498.3M
Property Plant And Equipment Gross	2.6B	2.7B	5.2B	5.7B	5.8B	6.1B
Accumulated Other Comprehensive Income	(372.4M)	(161.9M)	(192M)	(493.2M)	(59.3M)	(62.3M)
Other Liab	1.3B	1.4B	1.2B	1.1B	1.2B	702.7M
Other Assets	356.5M	350.9M	484.2M	440.3M	506.3M	531.7M
Long Term Debt	5.8B	5.4B	5.4B	5.0B	4.1B	3.1B
Property Plant Equipment	2.7B	2.8B	2.8B	3.0B	3.4B	3.6B
Good Will	7.9B	7.8B	8.0B	8.1B	6.1B	4.4B
Current Deferred Revenue	451M	506.5M	558.5M	582.1M	421.7M	442.8M
Net Tangible Assets	(4.3B)	(2.4B)	(1.4B)	(2.0B)	(1.8B)	(1.9B)
Long Term Debt Total	5.9B	5.5B	5.5B	5.1B	5.9B	4.8B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Global Correlations Find global opportunities by holding instruments from different markets
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.123

Dividend Share

2.88

Earnings Share

4.62

Revenue Per Share

142.986

Quarterly Revenue Growth

0.046

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Capital Surpluse vs Net Tangible Assets Analysis

Capital Surpluse vs Net Tangible Assets

Capital Surpluse vs Net Tangible Assets Correlation Analysis

Correlation Coefficient

Capital Surpluse

Net Tangible Assets

Laboratory fundamental ratios Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Laboratory Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Assets Total	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Stockholder Equity
Short Long Term Debt Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.36	Non Currrent Assets Other
Short Term Debt	- 0.24	Cash And Short Term Investments
Short Term Debt	- 0.24	Cash
Short Term Debt	- 0.23	Non Current Liabilities Total
Short Term Debt	- 0.22	Other Stockholder Equity
Common Stock Total Equity	- 0.17	Non Currrent Assets Other